October 2010, Cambridge, UK – BioWisdom Ltd (BioWisdom), the market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces a further 3 year agreement with AstraZeneca.
 |
BioWisdom AstraZeneca SIP Press Release Sept 2010 |
Read more about Biowisdom Extends Partnership With Astrazeneca For Safety Intelligence Program »
In this SIP series webinar Dave Cook from Astrazeneca’s Global Safety Assessment Team presents Astrazeneca’s experience of using SIP.
 | BioWisdom SIP Webinar 15 Jan 2009 |
|
BioWisdom SIP Webinar 15 Jan 2009 - AstraZeneca slides |
20 May 2009, Cambridge, UK – BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces that its Safety Intelligence Program has been awarded a prestigious “Best Practices” award at the recent Bio-IT World Life Sciences Conference and Expo in Boston.
Read more about BioWisdom’s Safety Intelligence Program Win’s ‘Best Practice’ Award for... »
BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that AstraZeneca, one of the world’s leading pharmaceutical companies, has selected them to apply the Sofia platform to generate a rich vocabulary and assertional meta-data from thousands of AstraZeneca-owned toxicology reports.
Read more about Biowisdom Selected by AstraZeneca to Create Custom Vocabulary Assertional... »